Stockreport

Argenx SE – ADR (ARGX) Sentiments Bolstered on Vyvgart FDA Priority Review Milestone [Yahoo! Finance]

argenx SE - American Depositary Shares  (ARGX) 
PDF sentiment boosted after the US Food and Drug Administration accepted priority review for a supplemental biologics license application for the immune disorder drug Vyvgar [Read more]